Spotlight on Dasatinib in Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia†

ISSN： 1173-8804

Source： BioDrugs, Vol.26, Iss.1, 2012-02, pp. : 61-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dasatinib: In Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

By Keam Susan J.

BioDrugs, Vol. 22, Iss. 1, 2008-01 ,pp. : 59-69

Adis International

Access to resources Recommend Favorite

Spotlight on Imatinib Mesylate in Chronic Myeloid Leukemia

By Curran M.P. Croom K.F. Goa K.L.

BioDrugs, Vol. 18, Iss. 3, 2004-01 ,pp. : 207-210

Adis International

Access to resources Recommend Favorite

Activity and Safety of Dasatinib as Second-Line Treatment or in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients

By Breccia Massimo Alimena Giuliana

BioDrugs, Vol. 25, Iss. 3, 2011-06 ,pp. : 147-157

Adis International

Access to resources Recommend Favorite

A novel mutation of SETBP1 in atypical chronic myeloid leukemia transformed from acute myelomonocytic leukemia

Clinical Case Reports, Vol. 3, Iss. 6, 2015-06 ,pp. : 448-452

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diagnosis of intrachromosomal amplification of chromosome 21 (iAMP21) by molecular cytogenetics in pediatric acute lymphoblastic leukemia

Clinical Case Reports, Vol. 3, Iss. 10, 2015-10 ,pp. : 814-816

John Wiley & Sons Inc

Access to resources Recommend Favorite